Comparison of telerehabilitation methods for systemic sclerosis patients in the COVID-19 era: A randomized controlled study

Background: Scleroderma (SSc) is an autoimmune connective tissue disease progressing with fibrosis. SSc patients need to be protected from epidemic diseases as well as rehabilitation needs. For this reason, it is important for them to continue their exercises in an environment where they can be both rehabilitated and protected from infectious diseases.